BioLight Life Sciences Investments Ltd and Aerie Pharmaceuticals, Inc. Affiliates Announce a Collaboration for Continued Development of a Controlled-Release Ocular Implant for the Delivery of Ophthalmic Medications

Published: Nov 07, 2012

TEL AVIV, Israel & BEDMINSTER, N.J., Nov. 6, 2012 (GLOBE NEWSWIRE) -- ViSci Ltd., a wholly owned subsidiary of BioLight Ltd. (TASE:BOLT) entered into an option agreement with Novaer LLC, an affiliate of Aerie Pharmaceuticals Inc., to license the Eye-DTM technology for further development of a sub-conjunctival drug implant for the controlled release of ophthalmic medications.

Back to news